Moster M L, Galetta S L, Schatz N J
Department of Neurosensory Sciences, Albert Einstein Medical Center, Philadelphia, Pennsylvania, USA.
Surv Ophthalmol. 1996 Mar-Apr;40(5):395-9. doi: 10.1016/s0039-6257(96)80068-3.
Neuroimaging with nuclear medicine techniques permits assessment of brain function by measurement of metabolism or blood flow. Such studies complement the anatomic information derived from computed tomography (CT) or magnetic resonance imaging (MRI). We describe two patients with occipital lesions who were initially diagnosed with functional visual loss. Neither CT scan nor MRI adequately demonstrated the source of visual dysfunction; however, single proton emission tomography (SPECT) scanning in a patient with carbon monoxide poisoning and positron emission tomography (PET) scanning in a patient with post-hypoxic delayed encephalopathy were helpful in confirming the organic substrate of their visual impairment. Functional imaging techniques such as SPECT and PET should be considered in patients with suspected cortical visual loss and normal CT or MR scans.
